POLYPHOR
DEAD

Serial Number

79212487

Owner

Polyphor AG

Attorney

Scott D. Woldow

Filing Date

Mar 10, 2017

Add to watchlist:

No watchlists yet
View on USPTO

POLYPHOR Trademark

Serial Number: 79212487 • Registration: 5393654

POLYPHOR is a trademark filed by Polyphor AG on March 10, 2017. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Polyphor AG (8 trademarks)

Hegenheimermattweg 125
Allschwil CH4123 , CH

Entity Type: 99

Trademark Details

Filing Date

March 10, 2017

Registration Date

February 6, 2018

Published for Opposition

November 21, 2017

Cancellation Date

August 23, 2024

Goods & Services

Pharmaceutical, veterinary and sanitary products, namely, Pharmaceutical anti-allergic preparations and substances, Pharmaceutical for the treatment of erectile dysfunction, Pharmaceutical preparations, namely, anticoagulants, Pharmaceutical preparations, namely, antidepressants, Pharmaceutical preparations, namely, appetite suppressants, Pharmaceutical preparations for use in chemotherapy, Pharmaceutical preparation for the treatment of gout, Pharmaceutical preparations for the treatment of heart rhythm disorders, Pharmaceutical preparations for the treatment of stem cell mobilization, Pharmaceutical preparations for the treatment of infectious diseases, Pharmaceutical preparations acting on the central nervous system, Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases, Pharmaceutical preparations for animal skincare, Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension, Pharmaceutical preparations for ocular or intraocular surgery, Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis, Pharmaceutical preparations for treating allergic rhinitis and asthma, Pharmaceutical preparations for treating diabetes, Pharmaceutical preparations for treating skin disorders, Pharmaceutical preparations for use in dermatology, Pharmaceutical preparations for wounds, Pharmaceutical preparations for use in urology, Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine, Pharmaceutical products and preparations against dry skin caused by pregnancy, Pharmaceutical products and preparations for chloasma, Pharmaceutical products and preparations for hydrating the skin during pregnancy, Pharmaceutical products and preparations for pregnancy blemishes, Pharmaceutical products and preparations for preventing skin blemishes during pregnancy, Pharmaceutical products and preparations to prevent stretch marks, Pharmaceutical products and preparations to prevent swelling in the legs, Pharmaceutical products for ophthalmological use, Pharmaceutical products for skin care for animals, Pharmaceutical products for the treatment of bone diseases, Pharmaceutical products for the treatment of viral and infectious diseases and for the treatment of cancer, Pharmaceutical products for treating respiratory diseases and asthma, Pharmaceutical skin lotions, Pharmaceutical solutions used in dialysis, Pharmaceuticals, namely, antihelmintics, Pharmaceuticals, namely, inducers of erections, Pharmaceuticals, namely, lipid lowering agents, Pharmaceuticals, namely, psychotropics, Pharmaceuticals, namely, anti-infectives; Veterinary preparations, namely, pain relief medication, veterinary preparations for the treatment of intestinal bacteria, Veterinary vaccine for horses, Veterinary vaccines; sanitary preparations for medical purposes; disinfectants; products for destroying vermin, namely, vermin destroying preparations; fungicides, herbicides

Chemicals used in industry, science, agriculture, horticulture and silviculture, except fungicides, herbicides, insecticides and parasiticides; unprocessed artificial resins, unprocessed plastics; soil fertilizers; chemical substances for preserving foodstuffs, namely, food preservatives; adhesives used in industry

Research, consultancy, and product development based on internal and customer data in the field chemistry regarding chemicals and resins; Planning of information technology systems for others based on internal and customer data in the field chemistry for researching chemicals and resins

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Aug 22, 2025 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Aug 7, 2025 INTS
INVALIDATION PROCESSED
Aug 6, 2025 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Apr 23, 2025 INTR
CANCELLED SECTION 71
Aug 23, 2024 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 6, 2023 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Oct 29, 2022 NREP
NEW REPRESENTATIVE AT IB RECEIVED
May 7, 2022 NREP
INTERNATIONAL REGISTRATION RENEWED
Jan 24, 2019 RNWL
NEW REPRESENTATIVE AT IB RECEIVED
Jul 19, 2018 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 22, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 14, 2018 FICS
FINAL DISPOSITION PROCESSED
May 14, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 6, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 6, 2018 R.PR
LIMITATION FROM THE IB EXAMINED AND ENTERED
Jan 22, 2018 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Nov 24, 2017 LIMG
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 21, 2017 NPUB
PUBLISHED FOR OPPOSITION
Nov 21, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 1, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 2, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 22, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 22, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 22, 2017 TROA
REFUSAL PROCESSED BY IB
Aug 11, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 27, 2017 RFCS
REFUSAL PROCESSED BY MPU
Jul 27, 2017 RFRR
APPLICATION FILING RECEIPT MAILED
Jul 25, 2017 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 21, 2017 RFCR
NON-FINAL ACTION WRITTEN
Jul 20, 2017 CNRT
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 19, 2017 ADCH
ASSIGNED TO EXAMINER
Jul 19, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 19, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 14, 2017 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jul 13, 2017 SDRC